Page last updated: 2024-09-03

n-succinimidyl-3-(tri-n-butylstannyl)benzoate and Glial Cell Tumors

n-succinimidyl-3-(tri-n-butylstannyl)benzoate has been researched along with Glial Cell Tumors in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bigner, DD; Garg, PK; Schuster, JM; Zalutsky, MR1
Bigner, DD; Colapinto, EV; Garg, PK; Noska, MA; Zalutsky, MR1

Other Studies

2 other study(ies) available for n-succinimidyl-3-(tri-n-butylstannyl)benzoate and Glial Cell Tumors

ArticleYear
Improved therapeutic efficacy of a monoclonal antibody radioiodinated using N-succinimidyl-3-(tri-n-butylstannyl)benzoate.
    Cancer research, 1991, Aug-15, Volume: 51, Issue:16

    Topics: Animals; Antibodies, Monoclonal; Benzoates; Cell Adhesion Molecules, Neuronal; Cell Line; Extracellular Matrix Proteins; Glioma; Humans; Immunotherapy; Iodine Radioisotopes; Male; Mice; Mice, Nude; Neoplasm Transplantation; Tenascin; Tissue Distribution; Transplantation, Heterologous; Trialkyltin Compounds

1991
Enhanced tumor localization and in vivo stability of a monoclonal antibody radioiodinated using N-succinimidyl 3-(tri-n-butylstannyl)benzoate.
    Cancer research, 1989, Oct-15, Volume: 49, Issue:20

    Topics: Animals; Antibodies, Monoclonal; Benzoates; Cell Adhesion Molecules, Neuronal; Glioma; Immunoglobulin G; Immunotoxins; Iodine Radioisotopes; Mice; Mice, Nude; Neoplasms, Experimental; Radiation Dosage; Tenascin; Tissue Distribution; Trialkyltin Compounds

1989